Clinical Trial Update: Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intensified daratumumab-based induction and consolidation in eligible newly diagnosed multiple myeloma patients (CTD-Dara re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia | Conditions: Multiple Myeloma Stage I | Phase 3 | Status: UNKNOWN